Timing of FFR-guided PCI for Non-IRA in NSTEMI and MVD (OPTION-NSTEMI)

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1. 1This trial is comparing different timing strategies for treating my non-culprit blocked arteries after a heart attack — can you explain what 'FFR-guided PCI' means in plain terms, and how the timing of that procedure might affect my recovery?
2. 2Since this trial is enrolling patients with multiple blocked coronary arteries alongside their heart attack, does my specific pattern of blockages make this kind of approach worth discussing, or would standard staged treatment be a more straightforward path for me?
3. 3The trial is measuring deaths, repeat heart attacks, and unplanned repeat procedures as its main outcomes — based on what you know about my case, which of those risks concerns you most right now, and how might participating in this study affect how those risks are managed?
4. 4Because this is listed as 'Phase NA,' which often applies to procedure-timing or strategy studies rather than new drugs, can you help me understand what is and isn't yet known about whether one timing approach is safer or more effective than the other?
5. 5If I were to consider this trial, what would the practical demands look like — such as extra hospital stays, additional procedures, or follow-up visits — and is that realistic given my current condition and recovery needs?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.